GlycoMimetics Inc (GLYC):企業の財務・戦略的SWOT分析

◆英語タイトル:GlycoMimetics Inc (GLYC) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH141235FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

GlycoMimetics Inc (GLYC) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

GlycoMimetics Inc (GlycoMimetics) is a clinical-stage biotechnology company that discovers, develops and commercializes small molecule drugs. The company’s pipeline products comprise uproleselan, rivipansel (GMI-1070), under phase III clinical trial is an anti-inflammatory compound to treat vaso-occlusive crisis of sickle cell disease and blood cancers. It is also designing galectin inhibitors for advancing treatment options of various diseases. GlycoMimetics designs and tests viral and bacterial entry inhibitors dendritic cell receptor. The company uses proprietary glycobiology technology to develop treatments for diseases. It also offers clinical research programs. GlycoMimetics is headquartered in Rockville, Maryland, the US.

GlycoMimetics Inc Key Recent Developments

Mar 02,2021: GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2020
Feb 23,2021: GlycoMimetics to Report Fourth Quarter and Year-End 2020 Financial Results on March 2
Nov 06,2020: GlycoMimetics reports highlights and financial results for third quarter 2020
Jul 31,2020: GlycoMimetics reports highlights and financial results for second quarter 2020
May 01,2020: GlycoMimetics reports operational highlights and financial results for first quarter 2020

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
GlycoMimetics Inc – Key Facts
GlycoMimetics Inc – Key Employees
GlycoMimetics Inc – Key Employee Biographies
GlycoMimetics Inc – Major Products and Services
GlycoMimetics Inc – History
GlycoMimetics Inc – Company Statement
GlycoMimetics Inc – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
GlycoMimetics Inc – Business Description
R&D Overview
GlycoMimetics Inc – Corporate Strategy
GlycoMimetics Inc – SWOT Analysis
SWOT Analysis – Overview
GlycoMimetics Inc – Strengths
GlycoMimetics Inc – Weaknesses
GlycoMimetics Inc – Opportunities
GlycoMimetics Inc – Threats
GlycoMimetics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
GlycoMimetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
GlycoMimetics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
GlycoMimetics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 02, 2021: GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2020
Feb 23, 2021: GlycoMimetics to Report Fourth Quarter and Year-End 2020 Financial Results on March 2
Nov 06, 2020: GlycoMimetics reports highlights and financial results for third quarter 2020
Jul 31, 2020: GlycoMimetics reports highlights and financial results for second quarter 2020
May 01, 2020: GlycoMimetics reports operational highlights and financial results for first quarter 2020
Feb 28, 2020: GlycoMimetics reports highlights and financial results for fourth quarter and year-end 2019
Jan 07, 2020: Apollomics buys AML programme rights in Greater China
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
GlycoMimetics Inc, Key Facts
GlycoMimetics Inc, Key Employees
GlycoMimetics Inc, Key Employee Biographies
GlycoMimetics Inc, Major Products and Services
GlycoMimetics Inc, History
GlycoMimetics Inc, Key Competitors
GlycoMimetics Inc, Ratios based on current share price
GlycoMimetics Inc, Annual Ratios
GlycoMimetics Inc, Annual Ratios (Cont...1)
GlycoMimetics Inc, Interim Ratios
GlycoMimetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
GlycoMimetics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
GlycoMimetics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[GlycoMimetics Inc (GLYC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Egyptian General Petroleum Corporation:石油・ガス:M&Aディール及び事業提携情報
    Summary Egyptian General Petroleum Corporation (EGPC), formerly General Petroleum Authority, is engaged in the oil and gas exploration services. The company is engaged in the refining, production, drilling, transportation and storage of crude oil; production of lubricants and greases; provides man p …
  • Constellation Pharmaceuticals Inc (CNST):企業の財務・戦略的SWOT分析
    Constellation Pharmaceuticals Inc (CNST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Ascent Resources plc (AST):企業の財務・戦略的SWOT分析
    Ascent Resources plc (AST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • High Peak Royalties Ltd (HPR):電力:M&Aディール及び事業提携情報
    Summary High Peak Royalties Limited (High Peak) is a leading utility company that builds a portfolio of diversified resource royalties with projects in exploration, pre-production and producing phases. It assesses a regular flow of potential royalty investments across the resources sector. The compa …
  • ICICI Lombard General Insurance Company Limited:企業の戦略・SWOT・財務情報
    ICICI Lombard General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary ICICI Lombard General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Petroleo Brasileiro SA (PETR4):企業の財務・戦略的SWOT分析
    Petroleo Brasileiro SA (PETR4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Electricity Authority of Cyprus:企業の戦略的SWOT分析
    Electricity Authority of Cyprus - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Vaxart Inc (VXRT):企業の財務・戦略的SWOT分析
    Vaxart Inc (VXRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Delphi Energy Corp (DEE):石油・ガス:M&Aディール及び事業提携情報
    Summary Delphi Energy Corp (Delphi Energy) is an independent oil and natural gas producing company. The company acquires and explores for, develops and produces crude oil and natural gas. It also carries out the production of natural gas liquids. Delphi Energy’s operations are primarily concentrated …
  • Funtastic Ltd (FUN):企業の財務・戦略的SWOT分析
    Funtastic Ltd (FUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • ARISCOM Compagnia di Assicurazioni S.p.A.:企業の戦略・SWOT・財務情報
    ARISCOM Compagnia di Assicurazioni S.p.A. - Strategy, SWOT and Corporate Finance Report Summary ARISCOM Compagnia di Assicurazioni S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Medtronic Plc (MDT):医療機器:M&Aディール及び事業提携情報
    Summary Medtronic Plc (Medtronic), formerly Medtronic Inc, is a medical technology company that designs, develops, manufactures and markets a wide range of medical devices and solutions for the treatment of heart failure; heart valve disorders; diseases of the coronary artery; aortic; peripheral vas …
  • MiMedx Group Inc – Product Pipeline Analysis, 2018 Uate
    Summary MiMedx Group Inc (MiMedx) is a biopharmaceutical company that develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary pur …
  • Inventiva (IVA)-製薬・医療分野:企業M&A・提携分析
    Summary Inventiva is a drug discovery company that endeavors to develop breakthrough therapies for cancer, fibrosis and rare diseases. The company’s product pipeline includes IVA336 for mucopolysaccharidosis type VI (MPS VI) and IVA337 for systemic sclerosis. Inventiva develops a novel internal canc …
  • Airgas Inc-医療機器分野:企業M&A・提携分析
    Summary Airgas Inc (Airgas), a subsidiary of Air Liquide S.A., is a supplier of industrial, medical, specialty gases and related equipment. The company also provides welding equipment, safety products, ammonia products, refrigerants, nitrous oxide, atmospheric gases, carbon dioxide and dry ice, weld …
  • Koninklijke Philips N.V.:企業のM&A・事業提携・投資動向
    Koninklijke Philips N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Koninklijke Philips N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • BioScrip Inc (BIOS):企業の財務・戦略的SWOT分析
    BioScrip Inc (BIOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • FANUC CORPORATION:企業の戦略・SWOT・財務情報
    FANUC CORPORATION - Strategy, SWOT and Corporate Finance Report Summary FANUC CORPORATION - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Mizuho Trust & Banking Co Ltd:企業の戦略・SWOT・財務分析
    Mizuho Trust & Banking Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Mizuho Trust & Banking Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • President Energy PLC (PPC):企業の財務・戦略的SWOT分析
    President Energy PLC (PPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆